STOK

STOK Net Income Growth

-496.12%TTM

Period ending:

STOK TTM Net Income YoY %%
STOK TTM Net Income YoY %228.29%-573.74%
2019-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

STOK net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 27 observations from Dec 31, 2019 to Jun 30, 2026.

Stoke Therapeutics Inc Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
-496.1245%
-437.6969%
92.2624%
138.4678%
150.6754%
146.3217%
15.0126%
-1.9933%
1.33%
-9.6652%
-3.5937%
-3.541%
-8.9459%
-5.6608%
-17.7868%
-31.5367%
-43.7893%
-61.4928%
-64.2421%
-58.6848%
-56.6929%
-54.1571%
-61.6179%
-80.8976%
-102.0888%
-130.0899%
-158.1663%

Compare net income growth

Other companies in Health Care. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All STOK financial metrics · STOK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.